General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 871: ANA antibody is seen in which of the following conditions?

A. Sarcoidosis (Correct Answer)
B. Tuberculosis
C. Leprosy
D. Carcinoid

Explanation: **Explanation:** **ANA (Antinuclear Antibody)** is a non-specific marker of autoimmunity [1]. While primarily associated with connective tissue disorders like SLE, it is also found in several chronic inflammatory and granulomatous conditions. **Why Sarcoidosis is correct:** Sarcoidosis is a multisystemic, idiopathic disorder characterized by non-caseating granulomas [3]. It involves significant immune dysregulation, including B-cell hyperreactivity and T-cell abnormalities. Approximately **10–30% of patients with Sarcoidosis** test positive for ANA [4]. While not a diagnostic criterion, its presence reflects the underlying autoimmune nature of the disease. **Analysis of Incorrect Options:** * **Tuberculosis (TB):** TB is caused by *Mycobacterium tuberculosis*. It is a chronic infectious disease characterized by caseating granulomas. While it involves the immune system, it does not typically trigger the production of antinuclear antibodies. * **Leprosy:** Caused by *Mycobacterium leprae*, this is a chronic infectious disease affecting nerves and skin. Although some autoantibodies (like Rheumatoid Factor) can occasionally be seen in lepromatous leprosy, ANA is not a characteristic feature. * **Carcinoid:** This is a neuroendocrine tumor (most commonly in the GI tract or lungs) that secretes serotonin. It is a neoplastic process, not an autoimmune or primary inflammatory granulomatous disease, and has no association with ANA. **High-Yield Clinical Pearls for NEET-PG:** * **Sarcoidosis Markers:** Elevated **Serum ACE (Angiotensin Converting Enzyme)** levels, hypercalcemia, and hypercalciuria are classic findings. * **Kveim-Siltzbach Test:** A historical skin test for Sarcoidosis (now rarely used). * **Bilateral Hilar Lymphadenopathy:** The most common radiological presentation of Sarcoidosis. * **ANA Patterns:** Remember that ANA is highly sensitive for SLE (95-99%) but has low specificity, as it can be positive in infections, malignancies, and healthy individuals [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 226. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 226-227. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 198-200. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 684-685.

Question 872: Hydrolytic degeneration is characterised by:

A. Caseation
B. Coagulation
C. Liquefaction (Correct Answer)
D. Fibrinoid

Explanation: **Explanation:** **Liquefactive necrosis** (Option C) is characterized by **hydrolytic degeneration**, where the tissue is transformed into a liquid, viscous mass [4]. This occurs because the catalytic enzymes (hydrolases) derived from either the lysosomes of the dead cells (autolysis) or from infiltrating inflammatory cells (heterolysis) completely digest the cellular architecture. This is the hallmark of focal bacterial or fungal infections and, uniquely, hypoxic death of cells within the Central Nervous System (CNS) [1]. **Why other options are incorrect:** * **Coagulative necrosis (Option B):** This is the most common pattern of necrosis [4]. It is characterized by the **denaturation of proteins** (including enzymes), which prevents proteolysis. This preserves the basic structural outline of the cell ("tombstone appearance") for several days. * **Caseous necrosis (Option A):** A form of coagulative necrosis typically seen in Tuberculosis [3]. It results in a "cheese-like" appearance due to a combination of protein denaturation and the presence of lipid-rich cell walls of Mycobacteria. * **Fibrinoid necrosis (Option D):** This is usually seen in immune-mediated vascular damage where complexes of antigens and antibodies are deposited in arterial walls, appearing as a bright pink, "fibrin-like" amorphous material. **High-Yield NEET-PG Pearls:** * **CNS Exception:** While ischemia in most organs causes coagulative necrosis, ischemia in the **Brain** causes liquefactive necrosis due to high lipid content and lack of supportive stroma [1]. * **Abscess formation:** This is the classic clinical example of liquefactive necrosis [2]. * **Key Enzyme:** The process is driven by **hydrolytic enzymes** (Hydrolases). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1268-1269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 192-193. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 55. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 53-55.

Question 873: Which of the following is NOT required for wound healing?

A. Zinc
B. Calcium (Correct Answer)
C. Copper
D. Vitamin C

Explanation: Wound healing is a complex process involving inflammation, proliferation, and remodeling. It requires specific vitamins and minerals as enzymatic cofactors. [1] **Why Calcium is the Correct Answer:** While **Calcium** is vital for blood coagulation (Factor IV) and bone mineralization, it is **not a direct requirement** for the biochemical processes of soft tissue wound healing or collagen synthesis. In the context of this classic pathology question, it is the "odd one out" compared to the other essential micronutrients. **Analysis of Incorrect Options:** * **Zinc (Option A):** Zinc is a mandatory cofactor for **Matrix Metalloproteinases (MMPs)**, which are enzymes responsible for remodeling the extracellular matrix and allowing cell migration. [1] Zinc deficiency leads to delayed wound healing and reduced tensile strength. * **Copper (Option C):** Copper is a cofactor for the enzyme **Lysyl Oxidase**. This enzyme is responsible for the cross-linking of collagen and elastin fibers, which provides structural integrity and tensile strength to the healing tissue. [1] * **Vitamin C (Option D):** Ascorbic acid is essential for the **hydroxylation of proline and lysine** residues during collagen synthesis. [2] Deficiency leads to Scurvy, characterized by poor wound healing and wound dehiscence due to defective collagen formation. **High-Yield NEET-PG Pearls:** * **Most important vitamin for wound healing:** Vitamin C. [2] * **Most important mineral for wound healing:** Zinc. [1] * **Tensile Strength:** At 1 week, a wound has ~10% of the strength of unwounded skin; it reaches ~70-80% by 3 months (it rarely reaches 100%). [3] * **Glucocorticoids:** These inhibit wound healing by decreasing TGF-̢ and reducing collagen synthesis. [2] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 450-451. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 116-117. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 119-121.

Question 874: Lipofuscin, the golden yellow pigment, is seen in heart muscles in which of the following conditions?

A. Atrophy (Correct Answer)
B. Hypertrophy
C. Infarction
D. Hyperplasia

Explanation: **Explanation:** **Lipofuscin**, also known as the "wear-and-tear" or "aging" pigment, is an insoluble brownish-yellow granular intracellular material [1]. It is composed of polymers of lipids and phospholipids complexed with protein, derived through the **peroxidation of polyunsaturated lipids** of subcellular membranes. **Why Atrophy is Correct:** Lipofuscin is a hallmark of free radical injury and lipid peroxidation. It is characteristically seen in cells undergoing slow, progressive **atrophy**, particularly in the heart and liver of elderly patients or those with severe malnutrition (cachexia) [1]. When the heart undergoes atrophy, the accumulation of this pigment gives the myocardium a dark appearance, a condition clinically termed **"Brown Atrophy of the heart."** It represents a tell-tale sign of past free radical damage. **Why Other Options are Incorrect:** * **Hypertrophy & Hyperplasia:** These are adaptations involving an increase in cell size or number, respectively, usually due to increased functional demand or hormonal stimulation. They are not primarily associated with the degradative autophagic processes that produce lipofuscin. * **Infarction:** This refers to localized area of ischemic necrosis. While cell injury occurs, the acute nature of infarction leads to coagulative necrosis rather than the chronic accumulation of aging pigments. **High-Yield NEET-PG Pearls:** * **Composition:** Lipofuscin is the end product of **autophagy**. * **Appearance:** On Light Microscopy, it appears as fine, golden-brown perinuclear granules [1]. * **Staining:** It is **Sudanophilic** (stains with fat stains) but is not cleared by solvents. * **Clinical Significance:** It is not toxic to the cell but serves as a marker of oxidative stress and chronological age. * **Distinction:** Do not confuse it with **Heomosiderin** (golden yellow but Prussic blue positive) or **Melanin** (black-brown). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 47-49, 75.

Question 875: Which of the following is not a labile cell?

A. Bone marrow
B. Epidermal cells
C. Small intestine mucosa
D. Hepatocytes (Correct Answer)

Explanation: **Explanation:** The classification of cells based on their proliferative capacity (the Cell Cycle) is a fundamental concept in pathology. Cells are categorized into three types: Labile, Stable, and Permanent. **Why Hepatocytes is the correct answer:** **Hepatocytes** are the classic example of **Stable (Quiescent) cells** [1]. These cells are normally in the $G_0$ phase of the cell cycle and have a low level of replication. However, they retain the capacity to rapidly enter the cell cycle ($G_1$ phase) in response to stimuli, such as liver injury or partial hepatectomy [2]. Because they are not continuously dividing under normal physiological conditions, they are not "labile." **Why the other options are incorrect:** * **A, B, and C (Bone marrow, Epidermal cells, Small intestine mucosa):** These are all **Labile (Continuously dividing) cells** [3]. These cells follow the "stem cell hierarchy" and are constantly being lost and replaced from a germinal layer [4]. They remain in the cell cycle throughout life to maintain tissue homeostasis. Other examples include the lining of the oral cavity, vagina, and transitional epithelium of the urinary tract. **High-Yield NEET-PG Pearls:** 1. **Permanent Cells:** These cells have left the cell cycle and cannot undergo division. Examples include **Neurons, Cardiac myocytes, and Skeletal muscle cells**. Injury to these tissues results in scarring (fibrosis), not regeneration. 2. **Regenerative Capacity:** The liver has the highest regenerative capacity among stable cells [1]. 3. **Stem Cells:** Labile tissues rely on adult stem cells (e.g., hematopoietic stem cells in bone marrow, crypt cells in the intestine) for constant replenishment [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 108-109. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 79-80. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-113. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 104-105.

Question 876: What is not true regarding Waldenstrom's macroglobulinemia?

A. Lymphadenopathy is usually present
B. Blood viscosity is increased
C. IgM immunoglobulin is increased
D. Hypercalcemia (Correct Answer)

Explanation: **Explanation:** Waldenström’s Macroglobulinemia (WM) is a B-cell neoplasm characterized by the infiltration of the bone marrow by **lymphoplasmacytic cells** that secrete a monoclonal **IgM** protein [1]. **Why Hypercalcemia is the correct answer (Not True):** Unlike Multiple Myeloma (MM), Waldenström’s Macroglobulinemia is typically **not** associated with lytic bone lesions, pathological fractures, or renal failure due to light chains [1]. Consequently, **hypercalcemia is rare** in WM. If a patient presents with significant bone destruction and hypercalcemia, the diagnosis is more likely to be Multiple Myeloma [2]. **Analysis of Incorrect Options:** * **Option A (Lymphadenopathy):** WM is a form of lymphoplasmacytic lymphoma. Unlike MM, which is confined to the marrow and bone, WM frequently involves the reticuloendothelial system, leading to **lymphadenopathy, splenomegaly, and hepatomegaly** in about 30-40% of cases [1]. * **Option B (Blood viscosity):** IgM is a large pentameric molecule. High levels significantly increase serum viscosity, leading to **Hyperviscosity Syndrome** (characterized by visual disturbances, neurological symptoms, and mucosal bleeding) [1]. * **Option C (IgM increased):** The hallmark of WM is a monoclonal "M spike" composed specifically of **IgM** [1]. **NEET-PG High-Yield Pearls:** * **Genetic Marker:** Over 90% of WM cases harbor the **MYD88 L265P mutation**. * **Clinical Triad:** Hyperviscosity, lymphadenopathy/splenomegaly, and absence of lytic bone lesions. * **Dutcher Bodies:** PAS-positive intranuclear inclusions of immunoglobulins are a classic morphological finding. * **Treatment of Hyperviscosity:** Emergency **plasmapheresis** is the gold standard for symptomatic relief. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 609-610. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 608-609.

Question 877: What is meant by the term "tumour progression"?

A. Spread of cancer to a distant site
B. Rate of growth of a tumour
C. The ability of cancer cells to resemble their normal counterparts
D. The sequential appearance of features of increasing malignancy (Correct Answer)

Explanation: **Explanation:** **Tumour progression** refers to the phenomenon where a tumour becomes increasingly aggressive and malignant over time [1]. This is driven by **genetic instability** and **clonality** [2]. As a tumour grows, sub-clones of cells undergo sequential mutations (the "multi-hit hypothesis") [2]. These mutations provide selective advantages, such as increased growth rate, invasiveness, and resistance to therapy [3]. Therefore, the correct answer is the **sequential appearance of features of increasing malignancy.** [1] **Analysis of Incorrect Options:** * **Option A (Spread to distant site):** This describes **Metastasis**, which is a hallmark of malignancy but only one specific component of the progression process [1]. * **Option B (Rate of growth):** This refers to the **Proliferation index** (often measured by Ki-67). While progression often leads to faster growth, the term "progression" encompasses broader phenotypic changes beyond just speed. * **Option C (Resemblance to normal counterparts):** This describes **Differentiation**. A lack of resemblance is termed **Anaplasia**. Tumour progression usually leads to *decreased* differentiation (dedifferentiation) [4]. **High-Yield NEET-PG Pearls:** * **Clonal Evolution:** Tumours are monoclonal in origin but become **polyclonal** due to progression, leading to "tumour heterogeneity" [4]. This explains why some cells in a tumour survive chemotherapy while others die [3]. * **Hallmarks of Progression:** Increased invasiveness, ability to survive in the circulation, and escaping immune surveillance. * **Key Concept:** Progression is not just an increase in size; it is a qualitative change in the biological behavior of the tumour cells [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 224-225. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 288-290. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 290. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 212-213.

Question 878: Which of the following is NOT associated with antibody-mediated paraneoplastic syndromes?

A. Stiff person syndrome
B. Necrotizing myelopathy (Correct Answer)
C. Limbic encephalopathy
D. Eaton Lambert syndrome

Explanation: Paraneoplastic syndromes (PNS) of the nervous system are divided into two categories: those mediated by **antibodies** (onconeural antibodies) and those resulting from **other mechanisms** (vascular, metabolic, or viral). [1] **Why Necrotizing Myelopathy is the correct answer:** Necrotizing myelopathy is a rare paraneoplastic condition characterized by rapid, symmetric ascending sensory and motor loss. Unlike the other options, its pathogenesis is **not antibody-mediated**. It is thought to result from **vascular compromise** (infarction), metabolic derangements, or a direct toxic effect of the underlying malignancy (most commonly lung cancer or lymphoma). It lacks a specific diagnostic onconeural antibody. **Analysis of Incorrect Options:** * **Stiff Person Syndrome:** Associated with **Anti-GAD (Glutamic Acid Decarboxylase)** or **Anti-amphiphysin** antibodies. It is often linked to breast cancer or small cell lung cancer (SCLC). * **Limbic Encephalopathy:** A classic antibody-mediated PNS presenting with memory loss and seizures. It is associated with **Anti-Hu** (SCLC) [1] or **Anti-NMDAR** (Ovarian teratoma) antibodies. * **Eaton-Lambert Syndrome:** Caused by antibodies against **P/Q-type voltage-gated calcium channels (VGCC)** at the neuromuscular junction, strongly associated with SCLC. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Small Cell Lung Cancer (SCLC)** is the most common malignancy associated with paraneoplastic neurological syndromes. [1] * **Anti-Hu (ANNA-1):** Most common antibody in paraneoplastic encephalomyelitis/sensory neuropathy. [1] * **Anti-Yo (PCA-1):** Associated with Paraneoplastic Cerebellar Degeneration (Breast/Ovarian cancer). * **Anti-Ri (ANNA-2):** Associated with Opsoclonus-Myoclonus syndrome (Breast/Lung cancer). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1235-1236. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1237-1238.

Question 879: All of the following are included in the pathogenesis of edema except?

A. Decreased hydrostatic pressure of capillaries (Correct Answer)
B. Decreased plasma osmotic pressure of capillaries
C. Lymphatic obstruction
D. Increased vascular permeability

Explanation: ### Explanation The formation of edema is governed by **Starling’s Law**, which describes the movement of fluid between the intravascular and interstitial compartments [4]. Edema occurs when there is an imbalance in these forces, leading to excess fluid accumulation in the interstitium [3]. **1. Why "Decreased hydrostatic pressure" is the correct answer:** Hydrostatic pressure is the "pushing force" that drives fluid out of the capillaries. For edema to occur, there must be an **increase** in hydrostatic pressure (e.g., in Congestive Heart Failure or Deep Vein Thrombosis) [1]. A **decrease** in hydrostatic pressure would actually favor fluid remaining within the vessel or being reabsorbed from the tissue, thereby preventing edema. **2. Analysis of Incorrect Options:** * **Decreased plasma osmotic pressure:** Plasma proteins (mainly albumin) exert oncotic pressure that "pulls" fluid into the vessel. A decrease in albumin (due to Nephrotic syndrome or Cirrhosis) leads to fluid leakage into tissues, causing edema [1]. * **Lymphatic obstruction:** Normally, lymphatics drain the small amount of fluid that leaks into the interstitium. Obstruction (e.g., Filariasis or post-surgical scarring) leads to **lymphedema** [2]. * **Increased vascular permeability:** In inflammation, chemical mediators cause gaps between endothelial cells, allowing fluid and proteins to leak out (Exudate), resulting in inflammatory edema [4]. **Clinical Pearls for NEET-PG:** * **Transudate vs. Exudate:** Edema due to increased hydrostatic pressure or low protein is a **Transudate** (low protein, low SG). Edema due to increased permeability is an **Exudate** (high protein, high SG). * **Most common cause of systemic edema:** Heart failure (increased hydrostatic pressure) and Renal failure (sodium/water retention) [2]. * **Kwashiorkor:** Edema is primarily due to **decreased oncotic pressure** from severe protein deficiency [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 124. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 124-126. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 124-125. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 186-187.

Question 880: Which of the following is characteristic of amyloidosis?

A. Beta pleated, metachromasia, PAS positive
B. Congophilic, beta pleated, PAS positive
C. Beta pleated, fibrillary, congophilic (Correct Answer)
D. Alpha pleated, small fibrils

Explanation: **Explanation:** Amyloidosis refers to a group of disorders characterized by the extracellular deposition of misfolded, insoluble proteins known as **amyloid**. The correct answer (Option C) highlights the three fundamental physical and staining properties used to identify amyloid in pathology: 1. **Beta-pleated sheet configuration:** Unlike normal proteins, all types of amyloid share a unique secondary structure where polypeptide chains are folded into cross-beta-pleated sheets [1]. This structure is responsible for its stability and resistance to proteolysis [2]. 2. **Fibrillary nature:** Under electron microscopy, amyloid appears as non-branching, linear, rigid fibrils (approximately 7.5 to 10 nm in diameter) [1], [2]. 3. **Congophilic:** Amyloid has a high affinity for **Congo red stain**. Under ordinary light, it appears pink/red; however, under polarized light, it exhibits a pathognomonic **apple-green birefringence** [1]. **Analysis of Incorrect Options:** * **Option A & B:** While amyloid is occasionally PAS positive (due to the presence of the P-component, a glycoprotein), it is **not** a defining characteristic. Furthermore, **metachromasia** (changing the color of a dye, e.g., Methyl violet/Crystal violet to violet-red) is a traditional screening method but is less specific than Congo red. * **Option D:** Amyloid is strictly **Beta-pleated**, not Alpha-pleated [1]. **NEET-PG High-Yield Pearls:** * **Most common form (Systemic):** AL (Light chain) amyloidosis, associated with Plasma Cell Dyscrasias [1]. * **Chronic Inflammation:** Associated with AA (Amyloid Associated) protein. * **Alzheimer’s Disease:** Characterized by $A\beta$ amyloid in the brain. * **Dialysis-associated:** $\beta_2$-microglobulin deposition. * **Gold Standard for Diagnosis:** Tissue biopsy (usually Abdominal Fat Pad or Rectal biopsy) followed by Congo Red staining [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 533-534.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free